vs

Side-by-side financial comparison of DIGI INTERNATIONAL INC (DGII) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

Harmony Biosciences Holdings, Inc. is the larger business by last-quarter revenue ($243.8M vs $122.5M, roughly 2.0× DIGI INTERNATIONAL INC). DIGI INTERNATIONAL INC runs the higher net margin — 9.6% vs 9.2%, a 0.3% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs 17.9%). Harmony Biosciences Holdings, Inc. produced more free cash flow last quarter ($126.0M vs $35.2M). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs 6.6%).

Digi International, Inc. is an American Industrial Internet of Things (IIoT) technology company based in Hopkins, Minnesota. Founded in 1985, they were best known in the early 1990s as a manufacturer of multi-line serial data serial cards for PC clones, allowing these machines to run multi-line bulletin board systems (BBSes). As this market began to wind down with the rise of the internet in the late 1990s, Digi began to concentrate on network attached devices and industrial monitoring.

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

DGII vs HRMY — Head-to-Head

Bigger by revenue
HRMY
HRMY
2.0× larger
HRMY
$243.8M
$122.5M
DGII
Growing faster (revenue YoY)
HRMY
HRMY
+3.2% gap
HRMY
21.1%
17.9%
DGII
Higher net margin
DGII
DGII
0.3% more per $
DGII
9.6%
9.2%
HRMY
More free cash flow
HRMY
HRMY
$90.9M more FCF
HRMY
$126.0M
$35.2M
DGII
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
6.6%
DGII

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DGII
DGII
HRMY
HRMY
Revenue
$122.5M
$243.8M
Net Profit
$11.7M
$22.5M
Gross Margin
62.4%
71.9%
Operating Margin
13.3%
15.8%
Net Margin
9.6%
9.2%
Revenue YoY
17.9%
21.1%
Net Profit YoY
16.1%
-54.6%
EPS (diluted)
$0.31
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGII
DGII
HRMY
HRMY
Q4 25
$122.5M
$243.8M
Q3 25
$114.3M
$239.5M
Q2 25
$107.5M
$200.5M
Q1 25
$104.5M
$184.7M
Q4 24
$103.9M
$201.3M
Q3 24
$105.1M
$186.0M
Q2 24
$105.2M
$172.8M
Q1 24
$107.7M
$154.6M
Net Profit
DGII
DGII
HRMY
HRMY
Q4 25
$11.7M
$22.5M
Q3 25
$10.0M
$50.9M
Q2 25
$10.2M
$39.8M
Q1 25
$10.5M
$45.6M
Q4 24
$10.1M
$49.5M
Q3 24
$11.9M
$46.1M
Q2 24
$9.7M
$11.6M
Q1 24
$4.0M
$38.3M
Gross Margin
DGII
DGII
HRMY
HRMY
Q4 25
62.4%
71.9%
Q3 25
63.9%
75.1%
Q2 25
63.5%
81.0%
Q1 25
62.1%
82.7%
Q4 24
62.0%
73.0%
Q3 24
61.1%
77.0%
Q2 24
59.2%
81.4%
Q1 24
57.9%
82.2%
Operating Margin
DGII
DGII
HRMY
HRMY
Q4 25
13.3%
15.8%
Q3 25
12.5%
27.3%
Q2 25
13.9%
24.0%
Q1 25
13.1%
30.4%
Q4 24
12.9%
27.7%
Q3 24
14.2%
33.2%
Q2 24
12.3%
12.4%
Q1 24
7.6%
33.7%
Net Margin
DGII
DGII
HRMY
HRMY
Q4 25
9.6%
9.2%
Q3 25
8.7%
21.2%
Q2 25
9.5%
19.8%
Q1 25
10.0%
24.7%
Q4 24
9.7%
24.6%
Q3 24
11.3%
24.8%
Q2 24
9.2%
6.7%
Q1 24
3.7%
24.8%
EPS (diluted)
DGII
DGII
HRMY
HRMY
Q4 25
$0.31
$0.38
Q3 25
$0.26
$0.87
Q2 25
$0.27
$0.68
Q1 25
$0.28
$0.78
Q4 24
$0.27
$0.85
Q3 24
$0.32
$0.79
Q2 24
$0.26
$0.20
Q1 24
$0.11
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGII
DGII
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$30.9M
$775.3M
Total DebtLower is stronger
$135.0M
$163.7M
Stockholders' EquityBook value
$649.2M
$870.2M
Total Assets
$918.4M
$1.3B
Debt / EquityLower = less leverage
0.21×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGII
DGII
HRMY
HRMY
Q4 25
$30.9M
$775.3M
Q3 25
$21.9M
$672.6M
Q2 25
$20.1M
$565.3M
Q1 25
$26.3M
$507.0M
Q4 24
$25.9M
$467.2M
Q3 24
$27.5M
$410.5M
Q2 24
$28.3M
$346.9M
Q1 24
$23.8M
$372.4M
Total Debt
DGII
DGII
HRMY
HRMY
Q4 25
$135.0M
$163.7M
Q3 25
$159.2M
$168.5M
Q2 25
$40.1M
$172.1M
Q1 25
$70.0M
$175.7M
Q4 24
$95.0M
$179.3M
Q3 24
$123.2M
$182.8M
Q2 24
$151.6M
$186.4M
Q1 24
$171.8M
$190.0M
Stockholders' Equity
DGII
DGII
HRMY
HRMY
Q4 25
$649.2M
$870.2M
Q3 25
$636.1M
$835.1M
Q2 25
$621.5M
$773.1M
Q1 25
$605.2M
$720.5M
Q4 24
$590.7M
$659.2M
Q3 24
$581.0M
$596.8M
Q2 24
$563.1M
$538.6M
Q1 24
$549.6M
$515.4M
Total Assets
DGII
DGII
HRMY
HRMY
Q4 25
$918.4M
$1.3B
Q3 25
$922.6M
$1.2B
Q2 25
$770.3M
$1.1B
Q1 25
$781.0M
$1.1B
Q4 24
$796.1M
$999.2M
Q3 24
$815.1M
$928.1M
Q2 24
$820.4M
$858.4M
Q1 24
$825.3M
$847.0M
Debt / Equity
DGII
DGII
HRMY
HRMY
Q4 25
0.21×
0.19×
Q3 25
0.25×
0.20×
Q2 25
0.06×
0.22×
Q1 25
0.12×
0.24×
Q4 24
0.16×
0.27×
Q3 24
0.21×
0.31×
Q2 24
0.27×
0.35×
Q1 24
0.31×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGII
DGII
HRMY
HRMY
Operating Cash FlowLast quarter
$35.6M
$126.2M
Free Cash FlowOCF − Capex
$35.2M
$126.0M
FCF MarginFCF / Revenue
28.7%
51.7%
Capex IntensityCapex / Revenue
0.4%
0.0%
Cash ConversionOCF / Net Profit
3.04×
5.61×
TTM Free Cash FlowTrailing 4 quarters
$111.4M
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGII
DGII
HRMY
HRMY
Q4 25
$35.6M
$126.2M
Q3 25
$28.0M
$108.7M
Q2 25
$24.0M
$79.3M
Q1 25
$26.3M
$34.0M
Q4 24
$29.7M
$75.6M
Q3 24
$26.4M
$70.5M
Q2 24
$24.9M
$42.6M
Q1 24
$13.1M
$31.1M
Free Cash Flow
DGII
DGII
HRMY
HRMY
Q4 25
$35.2M
$126.0M
Q3 25
$27.5M
$108.7M
Q2 25
$22.9M
$79.3M
Q1 25
$25.7M
$33.9M
Q4 24
$29.1M
$75.0M
Q3 24
$25.5M
$70.5M
Q2 24
$24.5M
$42.0M
Q1 24
$12.5M
$31.1M
FCF Margin
DGII
DGII
HRMY
HRMY
Q4 25
28.7%
51.7%
Q3 25
24.1%
45.4%
Q2 25
21.3%
39.6%
Q1 25
24.6%
18.3%
Q4 24
28.1%
37.3%
Q3 24
24.3%
37.9%
Q2 24
23.2%
24.3%
Q1 24
11.6%
20.1%
Capex Intensity
DGII
DGII
HRMY
HRMY
Q4 25
0.4%
0.0%
Q3 25
0.4%
0.0%
Q2 25
0.9%
0.0%
Q1 25
0.5%
0.1%
Q4 24
0.6%
0.3%
Q3 24
0.9%
0.0%
Q2 24
0.5%
0.4%
Q1 24
0.5%
0.0%
Cash Conversion
DGII
DGII
HRMY
HRMY
Q4 25
3.04×
5.61×
Q3 25
2.81×
2.14×
Q2 25
2.34×
1.99×
Q1 25
2.50×
0.75×
Q4 24
2.95×
1.53×
Q3 24
2.23×
1.53×
Q2 24
2.57×
3.68×
Q1 24
3.27×
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DGII
DGII

Io T Productsand Services$86.4M71%
Io T Solutions$36.1M29%

HRMY
HRMY

Segment breakdown not available.

Related Comparisons